Renal cell carcinoma associated with cyclophosphamide therapy for Wegener's granulomatosis

Scandinavian Journal of Rheumatology

Volumn 25, Issue 6, 1996, Pages 391-393

  Odeh, M ^a,b,c  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c NONE   (Israel)

Author keywords

cyclophosphamide; renal cell carcinoma; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

AGED; ARTICLE; CASE REPORT; HUMAN; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0030458857     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609065652     Document Type: Article

References (15)

1. Novack SN, Pearson, CM. Cyclophosphamide therapy in Wegener's granulomatosis. N Eng J Med 1971; 284: 938-42.
2. Watson NA, Notley RG. Urological complications of cyclophosphamide. Br J Urol 1973; 45: 606-9.
3. Stillwell TJ, Benson RC Jr. Cyclophosphamide induced hemorrhagic cystitis: a review of 100 patients. Cancer 1988; 61: 451-7.
4. Johnson WW, Meadows DC. Urinary-bladder fibrosis and telangiectasis associated with long-term cyclophosphamide therapy. N Engl J Med 1971; 284: 290-4.
5. Dale GA, Smith RB. Transitional cell carcinoma of the bladder associated with cyclophosphamide. J Urol 1974; 112: 603-4.
6. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996; 124: 477-84.
7. Ansell ID, Castro JE. Carcinoma of the bladder complicating cyclophosphamide therapy. Br J Urol 1975; 47: 413-8.
8. Fairchild WV, Spence CR, Solomon HD, Gangai MP. The incidence of bladder cancer after cyclophosphamide therapy. J Urol 1979; 122: 163-4.
9. Stillwell TJ, Benson RC, Jr, DeRemee RA, McDonald, TJ, Weiland, LH. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum 1988; 31: 465-70.
10. Stein JP, Skinner EC, Boyd SD, Skinner DG. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases. J Urol 1993; 149: 488-9.
11. Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978; 83: 492-502.
12. Hoover R, Fraumeni JF Jr. Risk of cancer in renal-transplant recipients. Lancet 1973; 2: 55-7.
13. Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man: chromosomal aberations, antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res 1975; 22: 57-155.
14. Chasko SB, Keuhnelian JG, Gutowski WT, Gray GF. Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis. Am J Surg Pathol 1980; 4: 191-6.
15. Sant GR, Ucci AA Jr, Meares EM Jr. Renal immunoblastic sarcoma complicating immunosuppressive therapy for Wegener's granulmatosis. Urology 1983; 21: 632-4.